In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Cohen, DJ; O'Shea, JC; Pacchiana, CM; Levine, G; Sarembock, I; Slater, J; Conn, E; Smith, J; Tcheng, JE; ESPRIT investigators,

Published Date

  • January 1, 2002

Published In

Volume / Issue

  • 89 / 1

Start / End Page

  • 61 - 64

PubMed ID

  • 11779525

Pubmed Central ID

  • 11779525

International Standard Serial Number (ISSN)

  • 0002-9149

Digital Object Identifier (DOI)

  • 10.1016/s0002-9149(01)02165-8

Language

  • eng

Conference Location

  • United States